CSBR vs OTLK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
OTLK Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Outlook Therapeutics, Inc. Common Stock (OTLK) driven by superior Valuation, Growth & Margin, Options & Structure while CSBR counters with relative strength in Momentum & Technical. Fundamentally, CSBR trades at 47.0x Forward P/E with -1.5% operating margin (+8.8% YoY revenue) versus OTLK at 2.9x Forward P/E and 4781.8% operating margin (-99.4% YoY). In options structure, CSBR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OTLK sits in BREAKDOWN (55th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CSBR | OTLK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $64.7M | $107.1M | Larger Scale | OTLK |
| Trailing P/E Ratio Valuation | 22.9x | 2.9x | Lower Multiple | OTLK |
| Forward P/E Ratio Valuation | 47.0x | 2.9x | Lower Multiple | OTLK |
| Revenue Growth (YoY) Growth | +8.8% | -99.4% | Higher Growth | CSBR |
| Operating Margin (TTM) Profitability | -1.5% | 4781.8% | Higher Margin | OTLK |
| Net Profit Margin Profitability | -1.9% | 0.0% | Higher Margin | OTLK |
| Return on Equity (ROE) Capital Efficiency | -28.4% | -3.6% | Higher ROE | OTLK |
| 52-Week Range Position Momentum | 5% ($5โ$8) | 10% ($0โ$3) | Stronger Trend | OTLK |
| Beta / 30D Volatility Risk Regime | 0.36ฮฒ ยท 24% Vol | 1.47ฮฒ ยท 79% Vol | Lower Realized Risk | CSBR |
| Unified Institutional Score Composite Signal | 42.9 / 100 (HOLD) | 48.6 / 100 (HOLD) | Higher Composite | OTLK |